ProShare Advisors’s Ascendis Pharma ASND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$391K Sell
2,265
-459
-17% -$79.2K ﹤0.01% 1264
2025
Q1
$425K Sell
2,724
-133
-5% -$20.7K ﹤0.01% 1187
2024
Q4
$393K Sell
2,857
-567
-17% -$78.1K ﹤0.01% 1433
2024
Q3
$511K Sell
3,424
-152
-4% -$22.7K ﹤0.01% 1124
2024
Q2
$488K Sell
3,576
-449
-11% -$61.2K ﹤0.01% 992
2024
Q1
$608K Buy
4,025
+361
+10% +$54.6K ﹤0.01% 976
2023
Q4
$461K Sell
3,664
-67
-2% -$8.44K ﹤0.01% 1088
2023
Q3
$349K Buy
3,731
+39
+1% +$3.65K ﹤0.01% 1126
2023
Q2
$330K Sell
3,692
-256
-6% -$22.8K ﹤0.01% 1210
2023
Q1
$423K Sell
3,948
-671
-15% -$71.9K ﹤0.01% 991
2022
Q4
$564K Sell
4,619
-48
-1% -$5.86K ﹤0.01% 913
2022
Q3
$482K Buy
4,667
+347
+8% +$35.8K ﹤0.01% 912
2022
Q2
$402K Sell
4,320
-1,418
-25% -$132K ﹤0.01% 1036
2022
Q1
$673K Sell
5,738
-2,051
-26% -$241K ﹤0.01% 1107
2021
Q4
$1.05M Sell
7,789
-3,389
-30% -$456K ﹤0.01% 993
2021
Q3
$1.78M Buy
11,178
+1,790
+19% +$285K 0.01% 746
2021
Q2
$1.24M Buy
9,388
+2,169
+30% +$285K ﹤0.01% 916
2021
Q1
$930K Sell
7,219
-775
-10% -$99.8K ﹤0.01% 1035
2020
Q4
$1.33M Buy
7,994
+464
+6% +$77.4K 0.01% 761
2020
Q3
$1.16M Buy
7,530
+154
+2% +$23.8K 0.01% 683
2020
Q2
$1.09M Buy
7,376
+1,059
+17% +$157K 0.01% 680
2020
Q1
$711K Sell
6,317
-3,595
-36% -$405K 0.01% 663
2019
Q4
$1.38M Sell
9,912
-2,453
-20% -$341K 0.01% 705
2019
Q3
$1.19M Sell
12,365
-787
-6% -$75.8K 0.01% 706
2019
Q2
$1.51M Sell
13,152
-532
-4% -$61.2K 0.01% 646
2019
Q1
$1.61M Buy
13,684
+236
+2% +$27.8K 0.01% 647
2018
Q4
$843K Sell
13,448
-2,656
-16% -$166K 0.01% 758
2018
Q3
$1.14M Buy
16,104
+264
+2% +$18.7K 0.01% 775
2018
Q2
$1.05M Buy
15,840
+750
+5% +$49.9K 0.01% 805
2018
Q1
$987K Sell
15,090
-2,160
-13% -$141K 0.01% 824
2017
Q4
$691K Buy
+17,250
New +$691K ﹤0.01% 986